119 related articles for article (PubMed ID: 4376499)
21. [Apropos of a case of mucocutaneous leishmaniasis resistant to antimonials and cured by amphotericin B in Guiana].
Chalchat P; Colas-Belcour J; Destombes P; Drouhet E; Fromentin H; Martin L; Ravisse P; Silverie J
Bull Soc Pathol Exot Filiales; 1965; 58(1):73-80. PubMed ID: 5898058
[No Abstract] [Full Text] [Related]
22. [Treatment of leishmaniasis in children].
Scappini JF; Harvey W
Arch Argent Pediatr; 1970 Dec; 68(10):369-70. PubMed ID: 5508182
[No Abstract] [Full Text] [Related]
23. [Observation of a South American skin leishmaniasis in Germany].
Halter K; Ruckes J
Z Haut Geschlechtskr; 1967 Apr; 42(7):239-44. PubMed ID: 5593786
[No Abstract] [Full Text] [Related]
24. Imported mucocutaneous leishmaniasis in New York City. Report of a patient treated with amphotericin B.
Singer C; Armstrong D; Jones TC; Spiro RH
Am J Med; 1975 Sep; 59(3):444-7. PubMed ID: 1163553
[TBL] [Abstract][Full Text] [Related]
25. Letter: Treatment of Saudi Arabian cutaneous leishmaniasis.
Morsy TA; Shoura MI
J Trop Med Hyg; 1974 Mar; 77(3):68. PubMed ID: 4830286
[No Abstract] [Full Text] [Related]
26. Mucocutaneous leishmaniasis: mucosal manifestations in an endemic country.
de Paulo LF; Rocha GF; Luisi CM; Rosa RR; Durighetto AF
Int J Infect Dis; 2013 Nov; 17(11):e1088-9. PubMed ID: 23867693
[No Abstract] [Full Text] [Related]
27. Risk factors for mucosal manifestation of American cutaneous leishmaniasis.
Machado-Coelho GL; Caiaffa WT; Genaro O; Magalhães PA; Mayrink W
Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):55-61. PubMed ID: 15550262
[TBL] [Abstract][Full Text] [Related]
28. [Protozoan infections of the skin].
Müller E; Sturm G
Hautarzt; 1974 Jun; 25(6):293-7. PubMed ID: 4546650
[No Abstract] [Full Text] [Related]
29. Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis.
Rocha RA; Sampaio RN; Guerra M; Magalhâes A; Cuba CC; Barreto AC; Marsden PD
J Trop Med Hyg; 1980 Aug; 83(4):131-9. PubMed ID: 6997505
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiologic survey of histoplasmosis, paracoccidioidomycosis and leishmaniasis using skin tests].
Naiff RD; Barrett TV; Arias JR; Naiff MF
Bol Oficina Sanit Panam; 1988 Jan; 104(1):35-50. PubMed ID: 2965883
[No Abstract] [Full Text] [Related]
31. [Mucocutaneous leishmaniasis in the province of Pichincha].
Rodríguez JD
Rev Ecuat Hig Med Trop; 1969; 26(1):3-7. PubMed ID: 5345517
[No Abstract] [Full Text] [Related]
32. [Epidemiological study of American cutaneous leishmaniasis in Maypuco, Peru].
Arzubiaga C; Huayanay J; Biaggioni I
Bol Oficina Sanit Panam; 1984 May; 96(5):417-24. PubMed ID: 6234001
[No Abstract] [Full Text] [Related]
33. An epidemiologic study of American cutaneous leishmaniasis in Maipuco, Peru.
Arzubiaga C; Huayanay J; Biaggioni I
Bull Pan Am Health Organ; 1984; 18(1):19-25. PubMed ID: 6733343
[No Abstract] [Full Text] [Related]
34. [Therapy of tegumental leishmaniasis].
Azulay RD
Hospital (Rio J); 1966 Nov; 70(5):1231-41. PubMed ID: 5301941
[No Abstract] [Full Text] [Related]
35. [Mucocutaneous leishmaniasis in Brazilian Amazonia].
Camuset G; Remy V; Hansmann Y; Christmann D; Gomes de Albuquerque C; Sena Casseb GA
Med Mal Infect; 2007 Jun; 37(6):343-6. PubMed ID: 17512150
[TBL] [Abstract][Full Text] [Related]
36. Patients' associations and the control of leishmaniasis in Peru.
Guthmann JP; Calmet J; Rosales E; Cruz M; Chang J; Dedet JP
Bull World Health Organ; 1997; 75(1):39-44. PubMed ID: 9141749
[TBL] [Abstract][Full Text] [Related]
37. [Management of American mucocutaneous leishmaniasis using 1-(5-nitro-2-thiazolyl)-2-imidazolidinone].
Furtado TA; Gontijo J; Viegas AC
Hospital (Rio J); 1969 Jan; 75(1):75-85. PubMed ID: 5304698
[No Abstract] [Full Text] [Related]
38. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of cutaneous leishmaniasis in Iran: B. Khorassan. 3. Human infection.
Nadim A; Rashti AS; Faghih A
Bull Soc Pathol Exot Filiales; 1969; 62(4):702-10. PubMed ID: 5409148
[No Abstract] [Full Text] [Related]
40. A randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis.
Rodriguez LV; Dedet JP; Paredes V; Mendoza C; Cardenas F
Mem Inst Oswaldo Cruz; 1995; 90(4):525-8. PubMed ID: 8551959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
